Trial intelligence / Profile preview

Azithromycin in COPD (BACE Trial)

NCT02205255Phase 3Completed

Start
Aug 2014
Primary completion
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of azithromycin in chronic obstructive pulmonary disease (COPD). Started Aug 2014; status: completed.

02

Drugs

azithromycin
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT02205255.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02205255.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call